Tempest Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() AKTX
Akari Therapeutics, Plc |
$1.38 | $17.67 M | -0.71 | 9 | $0 |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
![]() ARMP
Armata Pharmaceuticals, Inc. |
$2.09 | $98.34 M | -1.24 | 66 | $4.53 M |
![]() CBIO
Catalyst Biosciences, Inc. |
$0.51 | $19.42 M | -0.02 | 7 | $794,000 |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() CMRA
Comera Life Sciences Holdings, Inc. |
$0.00 | $706,969 | -0.1 | 12 | $633,102 |
![]() FBRX
Forte Biosciences, Inc. |
$22.60 | $21.25 M | -0.69 | 11 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() IKNA
Ikena Oncology, Inc. |
$1.66 | $84.45 M | -1.11 | 14 | $0 |
![]() INDP
Indaptus Therapeutics, Inc. |
$0.95 | $22.63 M | -1.5 | 7 | $0 |
![]() LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
![]() LYEL
Lyell Immunopharma, Inc. |
$0.68 | $619.50 M | -2.7 | 300 | $61,000 |
![]() OLMA
Olema Pharmaceuticals, Inc. |
$5.50 | $734.41 M | -6.56 | 87 | $0 |
![]() PCSA
Processa Pharmaceuticals, Inc. |
$0.94 | $4.72 M | -0.27 | 13 | $0 |
![]() RNXT
RenovoRx, Inc. |
$1.38 | $24.43 M | -1.46 | 8 | $0 |
![]() RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
![]() RZLT
Rezolute, Inc. |
$5.21 | $229.57 M | -5.02 | 64 | $0 |
![]() SANA
Sana Biotechnology, Inc. |
$1.75 | $1.55 B | -4.59 | 328 | $0 |
![]() SCPS
Scopus BioPharma Inc. |
$0.00 | $4,208 | 0 | 13 | $0 |
![]() THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
![]() ZIVO
ZIVO Bioscience, Inc. |
$19.90 | $21.15 M | -1.96 | 8 | $27,650 |
![]() ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.13 | $754.16 M | -3.26 | 124 | $0 |